Acme United Q2 2026 Earnings Beat Estimates on MyMedic Growth and Margin Expansion

• Acme United (ACU) reported Q2 2026 earnings per share of $1.22, significantly surpassing analyst estimates of $0.81 and marking a 50.62% upside surprise.
• Revenue reached $62.7 million, beating forecasts of $58.1 million by nearly 8%, driven primarily by a 16% year-over-year sales increase linked to the MyMedic acquisition.
• Gross margins expanded to 42.6% from 41.0% in the prior year period, reflecting initial cost management successes.
• Shares surged approximately 11.92% following the announcement, approaching a 52-week high of $51.88 as investors reacted positively to the financial turnaround.

Acme United delivered robust second-quarter 2026 financial results that exceeded market expectations across both top-line and bottom-line metrics. The company's earnings per share reached $1.22, a substantial improvement over the $0.81 consensus forecast, representing a 50.62% positive surprise. This performance marked a significant reversal from the first quarter of 2026, which had seen a miss on estimates, and signaled a strong recovery trajectory for the fiscal year.

Revenue growth was a key highlight, with total sales hitting $62.7 million against projected levels of $58.1 million. The 16% year-over-year increase in sales was largely attributed to the integration of the MyMedic acquisition, which provided a substantial boost to the top line. Excluding the impact of this acquisition, the company reported an organic growth rate of 8%, indicating underlying business resilience and steady demand across its core segments.

What Drives Acme United's Margin Recovery Outlook?

Operational efficiency gains were evident in the expansion of gross margins, which improved to 42.6% from 41.0% in the prior year period. This margin expansion highlights the company's ability to manage costs effectively despite broader inflationary pressures and supply chain challenges. Management remains optimistic about continued margin recovery, citing a strategic transition away from higher-cost inventory toward lower-cost stock as a primary driver.

CEO Johnsen emphasized that the company is actively working to mitigate the impact of tariffs by replacing higher-tariff inventory with lower-cost alternatives throughout the remainder of 2026. This inventory transition is expected to ease tariff pressures and further support profitability as the year progresses. The company also anticipates strong profitability in the fourth quarter, supported by seasonal demand patterns that typically benefit its product portfolio.

How is Acme United Integrating MyMedic and Managing Risks?

The integration of MyMedic remains a central strategic focus for Acme United, with plans to expand distribution channels beyond direct-to-consumer sales into mass retail. This expansion aims to diversify revenue streams and capitalize on the growing demand for first aid and medical supplies across broader market segments. The company's conservative balance sheet, characterized by a debt-to-equity ratio of 0.32, provides financial flexibility to support these strategic initiatives.

Despite the positive outlook, investors should remain aware of key risks associated with the current operational environment. Selling, general, and administrative (SG&A) expenses remain elevated at 32% of sales, which could potentially pressure net income if not managed effectively. Additional headwinds include potential fluctuations in tariff and freight costs, currency volatility, and uneven geographic performance, particularly in the Canadian market, which has lagged behind other regions.

Insider activity also warrants attention, as Acme United COO Brian Olschan exercised stock options for 20,000 shares valued at approximately $841,000 in mid-August 2026. This transaction, disclosed in a recent SEC Form 4 filing, occurred at a share price of around $61.53 and may signal management's confidence in the company's near-term prospects. While option exercises are often part of standard compensation structures, such actions by senior leadership are frequently viewed as bullish indicators by the market.

Acme United's strong Q2 2026 performance underscores the effectiveness of its acquisition strategy and cost management initiatives. As the company navigates tariff adjustments and expands its distribution networks, sustained execution will be critical to maintaining momentum. The upcoming fourth quarter will be closely watched for seasonal demand trends and further progress on margin recovery objectives.